Uterine sarcoma

Revision as of 17:15, 20 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Uterine sarcoma

Articles

Most recent articles on Uterine sarcoma

Most cited articles on Uterine sarcoma

Review articles on Uterine sarcoma

Articles on Uterine sarcoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Uterine sarcoma

Images of Uterine sarcoma

Photos of Uterine sarcoma

Podcasts & MP3s on Uterine sarcoma

Videos on Uterine sarcoma

Evidence Based Medicine

Cochrane Collaboration on Uterine sarcoma

Bandolier on Uterine sarcoma

TRIP on Uterine sarcoma

Clinical Trials

Ongoing Trials on Uterine sarcoma at Clinical Trials.gov

Trial results on Uterine sarcoma

Clinical Trials on Uterine sarcoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Uterine sarcoma

NICE Guidance on Uterine sarcoma

NHS PRODIGY Guidance

FDA on Uterine sarcoma

CDC on Uterine sarcoma

Books

Books on Uterine sarcoma

News

Uterine sarcoma in the news

Be alerted to news on Uterine sarcoma

News trends on Uterine sarcoma

Commentary

Blogs on Uterine sarcoma

Definitions

Definitions of Uterine sarcoma

Patient Resources / Community

Patient resources on Uterine sarcoma

Discussion groups on Uterine sarcoma

Patient Handouts on Uterine sarcoma

Directions to Hospitals Treating Uterine sarcoma

Risk calculators and risk factors for Uterine sarcoma

Healthcare Provider Resources

Symptoms of Uterine sarcoma

Causes & Risk Factors for Uterine sarcoma

Diagnostic studies for Uterine sarcoma

Treatment of Uterine sarcoma

Continuing Medical Education (CME)

CME Programs on Uterine sarcoma

International

Uterine sarcoma en Espanol

Uterine sarcoma en Francais

Business

Uterine sarcoma in the Marketplace

Patents on Uterine sarcoma

Experimental / Informatics

List of terms related to Uterine sarcoma


Overview

A uterine sarcoma is a malignant tumor that arises from the smooth muscle or connective tissue of the uterus. If the lesion originates from the stroma of the uterine lining it is an endometrial stromal sarcoma, and if the uterine muscle cell is the originator the tumor is a uterine leiomyosarcoma. A lesion that also contains malignant tumor cells of epithelial origin is termed uterine carcinosarcoma (formerly called malignant mixed mesodermal/mullerian tumor).

Prevalence

The vast majority of malignancies of the uterine body are endometrial carcinomas - only about 4% will be uterine sarcomas.[1] Generally, the cause of the lesion is not known, however patients with a history of pelvic radiation are at higher risk. Most tumors occur after the menopause. Women who take long-term tamoxifen are at higher risk. [2]

Signs and Symptoms

Unusual or postmenopausal bleeding may be a sign of a malignancy including uterine sarcoma and needs to be investigated. Other signs include pelvic pain, pressure, and unusual discharge. A nonpregnant uterus that enlarges quickly is suspicious. However, none of the signs are specific. Specific screening test have not been developed; a Pap smear is a screening test for cervical cancer and not designed to detect uterine sarcoma.

Diagnosis

Investigations by the physician include imaging (ultrasound, CAT scan, MRI) and, if possible, obtaining a tissue diagnosis by biopsy, hysteroscopy, or D&C. Ultimately the diagnosis is established by the histologic examination of the specimen. Typically malignant lesions have >10 mitosis per high power field. In contrast a uterine leiomyoma as a benign lesion would have < 5 mitosis per high power field.

Staging

Uterine sarcoma is staged like endometrial carcinoma at time of surgery using the FIGO cancer staging system.

  • Stage IA: tumor is limited to the endometrium
  • Stage IB: invasion of less than half the myometrium
  • Stage IC: invasion of more than half the myometrium
  • Stage IIA: endocervical glandular involvement only
  • Stage IIB: cervical stromal invasion
  • Stage IIIA: tumor invades serosa or adnexa, or malignant peritoneal cytology
  • Stage IIIB: vaginal metastasis
  • Stage IIIC: metastasis to pelvic or para-aortic lymph nodes
  • Stage IVA: invasion of the bladder or bowel
  • Stage IVB: distant metastasis, including intraabdominal or inguinal lymph nodes

Therapy

Therapy is based on staging and patient condition and utilizes one or more of the following approaches. Surgery is the mainstay of therapy if feasible involving total abdominal hysterectomy with bilateral salpingo-oophorectomy. Other approaches include radiation therapy, chemotherapy, and hormonal therapy.

See also

References

  1. [1] American Cancer Society information, accessed 03-11-2006
  2. [2] National Cancer Institute information, accessed 03-11-2006

External links

Template:WikiDoc Sources